Randall Colburn is a writer and editor at Entertainment Weekly. His work has previously appeared on The A.V. Club, The Guardian, The Ringer, and many other publications.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Staking is one of the most common ways crypto holders earn rewards simply by holding and committing their tokens to a blockchain network. Often described as “earning passive income in crypto,” staking ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

If you thought there was no possible way out for Claire Danes’ Aggie in the “The Beast in Me” finale episode, that was by design. Showrunner Howard Gordon — with whom Danes worked on “Homeland” — ...

‘Predator: Badlands’ sees a Yautja Predator hero team up with a damaged synthetic (Elle Fanning), and is full of unexpected twists—here’s the ending, explained. Predator: Badlands makes a bold move, ...

While yt-dlp-ejs and the external JavaScript runtimes are currently only used with YouTube, yt-dlp's usage of these may be expanded in the future (and necessarily so) If this guidance is insufficient, ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...